Found: 6
Select item for more details and to access through your institution.
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and safety of nab-paclitaxel 125 mg/m and nab-paclitaxel 150 mg/m compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 163, n. 3, p. 495, doi. 10.1007/s10549-017-4200-1
- By:
- Publication type:
- Article
Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08656-0
- By:
- Publication type:
- Article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08656-0
- By:
- Publication type:
- Article